Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 84

1.

Identification of the genes expression profile associated with the ex vivo resistance to etoposide in childhood acute leukemias.

Szczepanek J, Styczyński J, Tretyn A, Pogorzała M, Wysocki M.

Postepy Hig Med Dosw (Online). 2012 Jun 19;66:401-8.

2.

Gene expression signatures and ex vivo drug sensitivity profiles in children with acute lymphoblastic leukemia.

Szczepanek J, Jarzab M, Oczko-Wojciechowska M, Kowalska M, Tretyn A, Haus O, Pogorzala M, Wysocki M, Jarzab B, Styczynski J.

J Appl Genet. 2012 Feb;53(1):83-91. doi: 10.1007/s13353-011-0073-x. Epub 2011 Oct 27.

PMID:
22038456
3.

Expression profiles of signal transduction genes in ex vivo drug-resistant pediatric acute lymphoblastic leukemia.

Szczepanek J, Pogorzala M, Jarzab M, Oczko-Wojciechowska M, Kowalska M, Tretyn A, Wysocki M, Jarzab B, Styczynski J.

Anticancer Res. 2012 Feb;32(2):503-6.

PMID:
22287738
4.

Initial leukemic gene expression profiles of patients with poor in vivo prednisone response are similar to those of blasts persisting under prednisone treatment in childhood acute lymphoblastic leukemia.

Cario G, Fetz A, Bretscher C, Möricke A, Schrauder A, Stanulla M, Schrappe M.

Ann Hematol. 2008 Sep;87(9):709-16. doi: 10.1007/s00277-008-0504-x. Epub 2008 Jun 3.

PMID:
18521602
5.

Genomic and transcriptomic profiles and in vitro resistance to mitoxantrone and idarubicin in pediatric acute leukemias.

Laskowska J, Lewandowska-Bieniek J, Szczepanek J, Styczyński J, Tretyn A.

J Gene Med. 2016 Aug;18(8):165-79. doi: 10.1002/jgm.2889.

PMID:
27280600
6.

Predictive value of multidrug resistance proteins and cellular drug resistance in childhood relapsed acute lymphoblastic leukemia.

Styczynski J, Wysocki M, Debski R, Czyzewski K, Kolodziej B, Rafinska B, Kubicka M, Koltan S, Koltan A, Pogorzala M, Kurylak A, Olszewska-Slonina D, Balwierz W, Juraszewska E, Wieczorek M, Olejnik I, Krawczuk-Rybak M, Kuzmicz M, Kowalczyk J, Stefaniak J, Badowska W, Sonta-Jakimczyk D, Szczepanski T, Matysiak M, Malinowska I, Stanczak E, Wachowiak J, Konatkowska B, Gil L, Balcerska A, Maciejka-Kapuscinska L.

J Cancer Res Clin Oncol. 2007 Nov;133(11):875-93. Epub 2007 Aug 2. Erratum in: J Cancer Res Clin Oncol. 2007 Nov;133(11):895. Wachowiak, Jacek [added]; Konatkowska, Benigna [added]; Gil, Lidia [added]; Balcerska, Anna [added]; Maciejka-Kapuscinska, Lucyna [added].

PMID:
17671794
7.

Translocation t(12;21) is related to in vitro cellular drug sensitivity to doxorubicin and etoposide in childhood acute lymphoblastic leukemia.

Frost BM, Forestier E, Gustafsson G, Nygren P, Hellebostad M, Jonsson OG, Kanerva J, Schmiegelow K, Larsson R, Lönnerholm G.

Blood. 2004 Oct 15;104(8):2452-7. Epub 2004 Jun 24.

8.

MicroRNA characterize genetic diversity and drug resistance in pediatric acute lymphoblastic leukemia.

Schotte D, De Menezes RX, Akbari Moqadam F, Khankahdani LM, Lange-Turenhout E, Chen C, Pieters R, Den Boer ML.

Haematologica. 2011 May;96(5):703-11. doi: 10.3324/haematol.2010.026138. Epub 2011 Jan 17. Erratum in: Haematologica. 2011 Aug;96(8):1240.

9.

Gene-expression patterns in drug-resistant acute lymphoblastic leukemia cells and response to treatment.

Holleman A, Cheok MH, den Boer ML, Yang W, Veerman AJ, Kazemier KM, Pei D, Cheng C, Pui CH, Relling MV, Janka-Schaub GE, Pieters R, Evans WE.

N Engl J Med. 2004 Aug 5;351(6):533-42.

10.
11.

Association of high-level MCL-1 expression with in vitro and in vivo prednisone resistance in MLL-rearranged infant acute lymphoblastic leukemia.

Stam RW, Den Boer ML, Schneider P, de Boer J, Hagelstein J, Valsecchi MG, de Lorenzo P, Sallan SE, Brady HJ, Armstrong SA, Pieters R.

Blood. 2010 Feb 4;115(5):1018-25. doi: 10.1182/blood-2009-02-205963. Epub 2009 Dec 4.

12.

[Preliminary study of gene expression profile associated with risk classification of childhood patients with acute lymphoblastic leukemia].

Wang JL, Chai YH, Ji ZH, Shao XJ, Huang YP.

Zhonghua Xue Ye Xue Za Zhi. 2011 Jan;32(1):29-33. Chinese.

PMID:
21429398
13.

Relapse of acute lymphoblastic leukemia in children in the context of microarray analyses.

Szczepanek J, Styczyński J, Haus O, Tretyn A, Wysocki M.

Arch Immunol Ther Exp (Warsz). 2011 Feb;59(1):61-8. doi: 10.1007/s00005-010-0110-1. Epub 2011 Jan 19. Review.

PMID:
21246408
14.

The gene expression signature of relapse in paediatric acute lymphoblastic leukaemia: implications for mechanisms of therapy failure.

Beesley AH, Cummings AJ, Freitas JR, Hoffmann K, Firth MJ, Ford J, de Klerk NH, Kees UR.

Br J Haematol. 2005 Nov;131(4):447-56.

PMID:
16281934
15.

[Cytogenetics and in vitro drug resistance of acute leukemia in children and adults].

Styczyński J, Haus O.

Postepy Hig Med Dosw (Online). 2006;60:527-37. Review. Polish.

16.

The expression of 70 apoptosis genes in relation to lineage, genetic subtype, cellular drug resistance, and outcome in childhood acute lymphoblastic leukemia.

Holleman A, den Boer ML, de Menezes RX, Cheok MH, Cheng C, Kazemier KM, Janka-Schaub GE, Göbel U, Graubner UB, Evans WE, Pieters R.

Blood. 2006 Jan 15;107(2):769-76. Epub 2005 Sep 27.

17.

Fludarabine, treosulfan and etoposide sensitivity and the outcome of hematopoietic stem cell transplantation in childhood acute myeloid leukemia.

Styczynski J, Toporski J, Wysocki M, Debski R, Chybicka A, Boruczkowski D, Wachowiak J, Wojcik B, Kowalczyk J, Gil L, Balwierz W, Matysiak M, Krawczuk-Rybak M, Balcerska A, Sonta-Jakimczyk D.

Anticancer Res. 2007 May-Jun;27(3B):1547-51.

18.

Gene-expression profiles and their association with drug resistance in adult acute myeloid leukemia.

Heuser M, Wingen LU, Steinemann D, Cario G, von Neuhoff N, Tauscher M, Bullinger L, Krauter J, Heil G, Döhner H, Schlegelberger B, Ganser A.

Haematologica. 2005 Nov;90(11):1484-92.

19.

DNA microarrays for comparison of gene expression profiles between diagnosis and relapse in precursor-B acute lymphoblastic leukemia: choice of technique and purification influence the identification of potential diagnostic markers.

Staal FJ, van der Burg M, Wessels LF, Barendregt BH, Baert MR, van den Burg CM, van Huffel C, Langerak AW, van der Velden VH, Reinders MJ, van Dongen JJ.

Leukemia. 2003 Jul;17(7):1324-32. Erratum in: Leukemia. 2004 May;18(5):1041.

PMID:
12835720
20.

Distinct gene expression profiles determine molecular treatment response in childhood acute lymphoblastic leukemia.

Cario G, Stanulla M, Fine BM, Teuffel O, Neuhoff NV, Schrauder A, Flohr T, Schäfer BW, Bartram CR, Welte K, Schlegelberger B, Schrappe M.

Blood. 2005 Jan 15;105(2):821-6. Epub 2004 Sep 23.

Supplemental Content

Support Center